Back to search

Article

A Novel Prognostic Metric Resolves the <i>MYCN</i> enigma <i>in Silico</i> and Points to a Biosynthetic Regulatory Shift Driven by <i>MYCN</i> Amplification in Neuroblastoma

2025-11-14

Abstract excerpt

Neuroblastoma (NB) is the most common extra-cranial solid tumour in children. Although MYCN amplification is typically indicative of a poor prognosis, the expression level of MYCN has a non-monotonic relationship with the clinical outcome. This paper proposes an explanation for this phenomenon, which is called the MYCN enigma in the literature. The p53/MYCN metric, which is a measure of the p53 protein level re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2cc7d26-271a-569b-a8a3-ac19c94e3318
DOI
10.1101/2025.11.13.688307
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel Prognostic Metric Resolves the <i>MYCN</i> enigma <i>in Silico</i> and Points to a Biosynthetic Regulatory Shift Driven by <i>MYCN</i> Amplification in NeuroblastomaDOI 10.1101/2025.11.13.688307
Select a neighboring publication to make it the new centre.